Alcoholism & Drug Abuse Weekly最新文献

{"title":"Consultants on the biggest concerns from treatment providers","authors":"Alison Knopf","doi":"10.1002/adaw.35091","DOIUrl":"https://doi.org/10.1002/adaw.35091","url":null,"abstract":"<p>A general session at the InUnity Alliance meeting this month featured two top consultants answering questions from the attendees. The consultants, Robert Kent, Esq., president of Kent Strategic Advisors, and Josh Rubin, vice president of Client Solutions at Health Management Associates, shared their advice on the business pressures facing the substance use disorder (SUD) treatment field today.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 41","pages":"6-7"},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Legalized online sports betting associated with increase in outpatient treatment for mental illness","authors":"Alison Knopf","doi":"10.1002/adaw.35089","DOIUrl":"https://doi.org/10.1002/adaw.35089","url":null,"abstract":"<p>In 2018, there was one state with legalized online sports betting. Now there are 31. That increase is associated with an increase in treatment for mental illness, researchers have found. Gambling disorder (GD) is in the category of substance use disorder (SUD), but this study suggested that GD itself increases mental health problems.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 41","pages":"3-4"},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gambling helpline director sentenced to prison for past theft","authors":"Alison Knopf","doi":"10.1002/adaw.35092","DOIUrl":"https://doi.org/10.1002/adaw.35092","url":null,"abstract":"<p>A man whose gambling addiction led him to steal $1 million from his employer, then to make amends by running a gambling helpline, has nevertheless been sentenced to a decade in prison for the 2024 theft. Philip Sullivan, 43, was director of the Florida Council on Compulsive Gambling hotline after he lost his job with Royal American, a real estate company where he was chief financial officer. He was charged in March 2024 with stealing $1.4 million from that company. He pleaded no contest this month, and Florida state judge Timothy Register sentenced him to prison. Character witnesses for Sullivan testified in court that the gambling addiction came after he was prescribed Adderall, a stimulant approved to treat attention deficit disorder.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 41","pages":"7-8"},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"In Case You Haven't Heard…","authors":"","doi":"10.1002/adaw.35095","DOIUrl":"https://doi.org/10.1002/adaw.35095","url":null,"abstract":"<p>We have all heard the explanations from vaping supporters about why e-cigarettes are preferable socially to nicotine replacement therapy, like patches. The key is “socially.” They like to “smoke” with friends, as they did with combustible cigarettes. However, there may be another reason: recent research has found that even everyday vaping delivers much more nicotine than was expected. Rochester Institute of Technology researchers found that everyday vaping is more potent than users anticipated. The work of Risa Robinson and colleagues will contribute to better testing. “We are looking for key indicators of harm and addiction,” said Robinson. “We have these for smoking; it is well understood. But vaping differs quite a bit from traditional cigarette smoking. We aim to mimic the natural use behaviors of vaping. We want lab testing to better represent the real world.” Vapers inhale more deeply to get more of the nicotine — and it “works.” Is vaping more addictive than smoking?</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 41","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Coming Up…","authors":"","doi":"10.1002/adaw.35094","DOIUrl":"https://doi.org/10.1002/adaw.35094","url":null,"abstract":"<p>The 50th annual The <b>AMERSA</b> conference will be held <b>November 12-14</b> in Washington, D.C. For more information, go to https://conference.amersa.org/</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 41","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Coming Up…","authors":"","doi":"10.1002/adaw.35094","DOIUrl":"https://doi.org/10.1002/adaw.35094","url":null,"abstract":"<p>The 50th annual The <b>AMERSA</b> conference will be held <b>November 12-14</b> in Washington, D.C. For more information, go to https://conference.amersa.org/</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 41","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"JAMA: Naloxone and reduced prescribing can't account for all of OD decline","authors":"Alison Knopf","doi":"10.1002/adaw.35087","DOIUrl":"https://doi.org/10.1002/adaw.35087","url":null,"abstract":"<p>Last week's issue of the <i>Journal of the American Medical Association (JAMA)</i> took a close look at the observed declines in opioid-related deaths with two studies published in the same issue: one on declines in opioid prescribing since 2010 and the other on an increase in access to naloxone.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 41","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"JAMA: Naloxone and reduced prescribing can't account for all of OD decline","authors":"Alison Knopf","doi":"10.1002/adaw.35087","DOIUrl":"https://doi.org/10.1002/adaw.35087","url":null,"abstract":"<p>Last week's issue of the <i>Journal of the American Medical Association (JAMA)</i> took a close look at the observed declines in opioid-related deaths with two studies published in the same issue: one on declines in opioid prescribing since 2010 and the other on an increase in access to naloxone.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 41","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Parents whose adult children face prison due to addiction: Is there help?","authors":"Alison Knopf","doi":"10.1002/adaw.35088","DOIUrl":"https://doi.org/10.1002/adaw.35088","url":null,"abstract":"<p>We have had many — too many — chances to interview parents of adult children who lost their children to overdose deaths. Some of these parents went on to found organizations to try to help other bereaved parents, and to try to prevent addiction. These are tragic stories that, however, as some parents tell us, have redeeming powers.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 41","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"DEA moves to ban four kratom-linked substances – but not kratom","authors":"Alison Knopf","doi":"10.1002/adaw.35093","DOIUrl":"https://doi.org/10.1002/adaw.35093","url":null,"abstract":"<p>On October 14, the Drug Enforcement Administration (DEA) proposed placing four substances linked to the plant kratom on Schedule I of the Controlled Substances Act. This is the schedule reserved for substances which have a high potential for abuse and have no medical use. Kratom leaf is explicitly not included, and in fact this is to protect whatever the not listed. Rather, the substances targeted must all exceed a certain threshold before falling into the banned schedule. These are 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl (MGPI), MGM-15, and MGM-16. They all have opioid-like qualities. 7-OH is found in trace amounts in kratom. The other three substances are synthetically derived from the plant. The DEA Federal Register notice also warned of deceptive branding in which these products were called “kratom” and marketed as medical treatments, energy supplements, and so on. The federal Department of Health and Human Services (HHS) also participates in such rulemaking when it comes to the abuse potential of drugs. On October 9, HHS made it clear that the DEA recommendation was designed to distinguish the four substances from “natural botanical kratom products,” which may contain trace amounts of the banned substances – hence the threshold criterion. “We are drawing a clear line between natural kratom and dangerous, enhanced opioid products,” said HHS Secretary Robert F. Kennedy, Jr. “We listened to the public, followed the science, and developed a clear recommended threshold for temporary scheduling that targets concentrated 7-OH and MGPI without sweeping natural botanical kratom into Schedule I. The Trump Administration will continue taking decisive action against dangerous products that fuel addiction while making sure our policies are grounded in rigorous science.” The National Institute on Drug Abuse is researching an active component of kratom, which explains the reticence to place kratom on Schedule I. For the DEA Federal Register notice, go to https://www.federalregister.gov/documents/2026/10/14/2026-20943/schedules-of-controlled-substances-temporary-placement-of-7--hydroxymitragynine-and-mitragynine</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 41","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}